BXC - BlueLinx topline in line with consensus

• BlueLinx ( NYSE: BXC ) Q3 shows topline revenue of $1.06B, in-line with consensus, up 9.2% Y/Y.
• Grew specialty product sales 13% to $724M, or 68% of total sales, consistent with growth strategy.
• Increased gross profit 24% to $189M and gross margin 210 basis points to 17.9%.
• Reported net income of $60M and grew adjusted EBITDA 27% to $100M and increased adjusted EBITDA margin 130 basis points to 9.4%.
• “Our third quarter results were highlighted by 9% year-over-year sales growth, 35% diluted EPS growth and 27% adjusted EBITDA growth,” said Dwight Gibson, President and Chief Executive Officer. “Specialty product sales grew 13% year-over-year to $724 million, or 68% of total sales, and gross profit from specialty product sales increased 3% to $151 million, or 80% of total gross profit. We generated $143 million of operating cash, a record level, which further strengthened our balance sheet. And we ended the quarter with net leverage of 0.7x, cash on hand of $229 million and available liquidity at an all-time high of $576 million.”
• GAAP EPS of $6.38 beats consensus by $0.47 .
• Contributor commentary: ' BlueLinx: Amazing Results, 5x 2023 EPS '
• SA Author rating of Buy , Sell-side rating of Strong Buy , and Quant rating Buy with highest factor grades given to valuation.
• Previously (Nov. 1): BlueLinx Holdings GAAP EPS of $6.38 beats by $0.47, revenue of $1.06B in-line

For further details see: